$Cognyte Software (CGNT.US)$ Value Base’s proposals receive support of Neuberger Berman, a leading global investment manager and a top shareholder of Cognyte, which intends to vote at the Cognyte Software AGM: Value Base, Cognyte Software's largest shareholder (9.33% stake), announces support from Neuberger Berman (7.16% stake) for its proposals at the upcoming AGM. Both major shareholders advocate for: Voting AGAINST Chairman Earl Shanks' re-election Voting AGAINST the CEO compensation plan ...
Cognyte Software股票讨论区
Value Base’s proposals receive support of Neuberger Berman, a leading global investment manager and a top shareholder of Cognyte, which intends to vote at the Cognyte Software AGM:
Value Base, Cognyte Software's largest shareholder (9.33% stake), announces support from Neuberger Berman (7.16% stake) for its proposals at the upcoming AGM. Both major shareholders advocate for:
Voting AGAINST Chairman Earl Shanks' re-election
Voting AGAINST the CEO compensation plan
...
智明科技与EMEA地区的国家安全机构签署了一项1000万美元的扩展合约
智明科技软件(NASDAQ: CGNT)宣布从EMEA地区的国家安全机构获得了一项1000万美元的跟单订单。长期合作伙伴将利用智明科技的高级调查分析能力从不断增长的数据量中获取更多的见解,并对恐怖主义、毒品走私和武器走私等威胁进行打击。此订单突显了客户对智明科技的技术和解决方案的满意度。
资讯
Cognyte将参加TD Cowen第52届年度科技、媒体和电信会议
Cognyte软件(纳斯达克:CGNT)宣布其首席执行官Elad Sharon和首席财务官David Abadi将参加TD Cowen第52届年度科技、媒体和电信会议的面向火灾的对话。
该活动将于2024年5月29日星期三上午10:15 Et举行。Cognyte的投资者关系网站上将提供在线实时网络直播和讨论的回放。
$辉瑞 (PFE.US)$ — 辉瑞发布了全年调整后盈利的指引后,这家生物制药股份下跌了7.4%...
$塔吉特 (TGT.US)$ +1.14%(Target宣布将其每股分红提高1.9%,即2美分,至每股1.10美元。)
$Aldeyra Therapeutics (ALDX.US)$ +7.89%(Aldeyra宣布其一种用于眼部炎症的药物在主要和所有次要终点上具有统计学意义。)
$达美乐比萨 (DPZ.US)$ +2.31%(这家比萨连锁店的股价上涨2.3%,斯蒂费尔将其评级从持有升级为买入。该公司...
2022年09月28日的科技板块行情:CGNt, INTC, Bb, Bb.TO $Cognyte Software (CGNT.US)$ 科技股在周三上涨,SPDR科技选择性etf上涨了0.5%,与此同时,费城半导体指数下午上涨了0.7%。
对收益/指导意见的反应:
• $索尔工业 (THO.US)$ 上涨2.5%
其他资讯:
• $Acumen Pharmaceuticals (ABOS.US)$+76.8% (in response with BIIB)
• $渤健公司 (BIIB.US)$ +45.6% (reports Lecanemab confirmatory Phase 3 Clarity AD study met primary endpoint)
• $Nano X Imaging (NNOX.US)$+22.8% (submitted a 510(k) premarket notification to the FDA on Sept 26 for its multisource 3D digital tomosynthesis system)
• $Ocugen (OCGN.US)$ +9.3%(en...
暂无评论